by Peter Ciszewski | Feb 5, 2021
Auris Huen, MD, PharmD, Assistant Professor, MD Anderson Cancer Center, Department of Dermatology provides an overview of Sézary Syndrome, a subtype of Cutaneous T-cell lymphoma (CTCL). Cutaneous T-cell lymphoma belongs to the non-Hodgkin lymphoma class of...
by Peter Ciszewski | Feb 4, 2021
Auris Huen, MD, PharmD, Assistant Professor, MD Anderson Cancer Center, Department of Dermatology provides an overview of Mycosis Fungoides, a subtype of cutaneous T-cell lymphoma (CTCL). Cutaneous T-cell lymphoma belongs to the non-Hodgkin lymphoma class of...
by Peter Ciszewski | Feb 2, 2021
Auris Huen, MD, PharmD, Assistant Professor, MD Anderson Cancer Center, Department of Dermatology discusses the challenges of diagnosing Cutaneous T-cell lymphoma (CTCL). The diagnosis of CTCL is often challenging; as a result, delays in diagnosis (and...
by Peter Ciszewski | Jan 30, 2021
Auris Huen, MD, PharmD, Assistant Professor, MD Anderson Cancer Center, Department of Dermatology, discusses treating Cutaneous T-cell lymphoma (CTCL). There are many, multimodal treatment options for the various CTCL subtypes. In addition to pharmacologic...
by Peter Ciszewski | Jan 28, 2021
Prilenia Therapeutics recently announced the enrollment of the first participant in Europe for its phase 3 clinical trial in Huntington disease patients. The PROOF-HD trial is a pivotal trial being conducted in North America and Europe in collaboration with the...
